national-clinical-guidelines-for-stroke-fourth-edition
national-clinical-guidelines-for-stroke-fourth-edition
national-clinical-guidelines-for-stroke-fourth-edition
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Evidence to recommendations<br />
Studies have shown that <strong>stroke</strong> patients are at high risk of developing dehydration,<br />
malnutrition, infections, hypoxia and hyperglycaemia. The evidence <strong>for</strong> <strong>stroke</strong> unit<br />
management rather than non-specialist care is robust. Middleton et al 2011 have shown<br />
that introducing protocols and training into <strong>stroke</strong> unit care can significantly improve<br />
outcomes. Management of blood pressure after <strong>stroke</strong> remains an area where there is<br />
little evidence to guide care and the recommendations made are based upon the<br />
consensus of the working party and the NICE Guideline Development Group. There is<br />
no evidence <strong>for</strong> the use of hyperbaric oxygen therapy in <strong>stroke</strong> (Bennett et al 2009) and<br />
from the evidence available, the working party feels that mannitol <strong>for</strong> the treatment of<br />
cerebral oedema should not be used outside of the context of a <strong>clinical</strong> trial.<br />
4.12.1 Recommendations<br />
A All patients with acute <strong>stroke</strong> should be admitted directly to a <strong>stroke</strong> unit that has<br />
protocols to maintain normal physiological status, and has staff trained in their use.<br />
B The patient’s physiological state should be monitored closely to include:<br />
● blood glucose<br />
● blood pressure<br />
● oxygenation<br />
● nourishment and hydration<br />
● temperature.<br />
C People who have had a <strong>stroke</strong> should receive supplemental oxygen only if their oxygen<br />
saturation drops below 95% and there is no contraindication. The routine use of<br />
supplemental oxygen is not recommended in people with acute <strong>stroke</strong> who are not<br />
hypoxic.<br />
D People with acute <strong>stroke</strong> should be treated to maintain a blood glucose concentration<br />
between 4 and 11 mmol/L.<br />
E Optimal insulin therapy, which can be achieved by the use of intravenous insulin and<br />
glucose, should be provided to all adults with diabetes who have <strong>stroke</strong>. Critical care<br />
and emergency departments should have a protocol <strong>for</strong> such management.<br />
F Antihypertensive treatment in people with acute <strong>stroke</strong> is recommended only if there<br />
is a hypertensive emergency or one or more of the following serious concomitant<br />
medical issues:<br />
● hypertensive encephalopathy<br />
● hypertensive nephropathy<br />
● hypertensive cardiac failure/myocardial infarction<br />
● aortic dissection<br />
● pre-eclampsia/eclampsia<br />
4 Acute phase care<br />
● intracerebral haemorrhage with systolic blood pressure over 200 mmHg.<br />
G Blood pressure reduction to 185/110 mmHg or lower should be considered in people<br />
who are candidates <strong>for</strong> thrombolysis.<br />
H Non-dysphagic patients admitted on antihypertensive medication should continue<br />
oral treatment unless there is a contraindication or they are being included in a trial<br />
of blood-pressure control.<br />
© Royal College of Physicians 2012 53